Suzuki, Rikio
Harvard University · Dana-Farber Cancer Institute
2 papers on CoChatORCID 0000-0002-2841-6230
Most cited papers
- Verified
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Görgün, G., Samur, M. K., Cowens, K. B., Paula, S., Bianchi, G., Anderson, J. E., White, R. E., Singh, A., Ohguchi, H., Suzuki, R., et al. (2015) · Clinical Cancer Research
Multiple Myeloma Research and TreatmentsCancer Immunotherapy and Biomarkers
Cited by 309
- Verified
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
Minami, J., Suzuki, R., Mazitschek, R., Gorgun, G., Ghosh, B., Cirstea, D., Hu, Y., Mimura, N., Ohguchi, H., Cottini, F., et al. (2014) · Leukemia
Histone Deacetylase Inhibitors ResearchMultiple Myeloma Research and Treatments
Cited by 159
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free